0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Commentary |

Prostate Cancer Screening—Time to Abandon One-Size-Fits-All Approach?

Jeri Kim, MD; John W. Davis, MD
JAMA. 2011;306(24):2717-2718. doi:10.1001/jama.2011.1881.
Text Size: A A A
Published online

Extract

The new US Preventive Services Task Force draft recommendations discourage use of prostate-specific antigen (PSA) screening among asymptomatic men, regardless of age, race, or family medical history.1 This one-size-fits-all recommendation derives from the overdiagnosis and overtreatment of many patients with PSA-screened asymptomatic prostate cancer; it cites a “statistically insignificant 0.06% absolute reduction in prostate cancer–specific deaths for men aged 50 to 74 years”1 after a median of 9 years in the European Randomized Study of Screening for Prostate Cancer.2 But is the current evidence sufficient to discourage PSA screening in asymptomatic men and ultimately remove PSA screening from optional testing if Medicare or third-party payers adopt the task force's recommendation?

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

April 4, 2012
Marc B. Garnick, MD
JAMA. 2012;307(13):1372-1374. doi:10.1001/jama.2012.396.
April 4, 2012
Andrew M. D. Wolf, MD; Robert J. Volk, PhD
JAMA. 2012;307(13):1372-1374. doi:10.1001/jama.2012.397.
April 4, 2012
Jeri Kim, MD; John W. Davis, MD
JAMA. 2012;307(13):1372-1374. doi:10.1001/jama.2012.398.
April 4, 2012
David C. Miller, MD, MPH; Brent K. Hollenbeck, MD, MS
JAMA. 2012;307(13):1372-1374. doi:10.1001/jama.2012.399.
CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 7

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles
Jobs
JAMAevidence.com

The Rational Clinical Examination
Seizures

brightcove.createExperiences();